Literature DB >> 7615755

Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19.

A L Bruu1, S A Nordbø.   

Abstract

The following commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19 were evaluated: Ideia Parvovirus B19-IgM, MRL Diagnostics Human Parvovirus B19 IgM ELISA, Parvoscan-B19, and Biotrin Parvo B19 IgM EIA and IF. A total of 203 serum specimens from patients who probably have current B19 infections or have other viral infections and sera with rheumatoid factor were investigated. Between 75 and 79 of 102 serum samples from patients thought to have current B19 infections yielded positive results with the different tests. Ideia had the highest specificity (94.8%), while Parvoscan showed a specificity of only 70.1%. Our evaluation results show that Ideia, MRL, and Biotrin EIA and IF can be recommended for diagnostic purposes.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7615755      PMCID： PMC228166          DOI： 10.1128/jcm.33.5.1363-1365.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Studies in laboratory estimation of rheumatoid arthritis serum factor. 3. Slide agglutination methods with and without sensitizing gamma globulin.

Authors:  S WINBLAD
Journal:  Acta Pathol Microbiol Scand       Date:  1960

2.  A new peptide for human parvovirus B19 antibody detection.

Authors:  E Fridell; J Trojnar; B Wahren
Journal:  Scand J Infect Dis       Date:  1989

Review 3.  Human parvovirus infection.

Authors:  R Ware
Journal:  J Pediatr       Date:  1989-03       Impact factor: 4.406

4.  Parvovirus infection after renal transplant.

Authors:  G Neild; M Anderson; S Hawes; B T Colvin
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

5.  Cross-reactions in rubella and parvovirus specific IgM tests.

Authors:  J B Kurtz; M J Anderson
Journal:  Lancet       Date:  1985-12-14       Impact factor: 79.321

6.  Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients.

Authors:  W C Koch; G Massey; C E Russell; S P Adler
Journal:  J Pediatr       Date:  1990-03       Impact factor: 4.406

7.  Human parvovirus B19: ELISA and immunoblot assays.

Authors:  T F Schwarz; M Roggendorf; F Deinhardt
Journal:  J Virol Methods       Date:  1988-06       Impact factor: 2.014

8.  Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease.

Authors: 
Journal:  BMJ       Date:  1990-05-05

9.  Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system.

Authors:  C S Brown; M M Salimans; M H Noteborn; H T Weiland
Journal:  Virus Res       Date:  1990-03       Impact factor: 3.303

10.  Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV).

Authors:  B J Cohen; P P Mortimer; M S Pereira
Journal:  J Hyg (Lond)       Date:  1983-08
View more
  8 in total

Review 1.  Parvovirus B19 infection in human pregnancy.

Authors:  R F Lamont; J D Sobel; E Vaisbuch; J P Kusanovic; S Mazaki-Tovi; S K Kim; N Uldbjerg; R Romero
Journal:  BJOG       Date:  2010-10-13       Impact factor: 6.531

2.  Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops.

Authors:  M Zerbini; M Musiani; G Gentilomi; S Venturoli; G Gallinella; R Morandi
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

3.  Effects of Parvovirus B19 Infection in Renal Transplant Recipients: A Retrospective Review of Three Cases.

Authors:  Prathik Krishnan; Poornima Ramadas; Prejith P Rajendran; Parvathy Madhavan; Asha Alex; Vivek Jayaschandran; Shaesta G Humayun; Nicole Ali; Mala Sachdeva; Antonette Flecha; Amit Basu; Madhu Bhaskaran; Ernesto P Molmenti
Journal:  Int J Angiol       Date:  2015-06

4.  Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19.

Authors:  T Sloots; P L Devine
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

5.  Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M.

Authors:  T Tolfvenstam; U Rudén; K Broliden
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

Review 6.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

Review 7.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

8.  Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis.

Authors:  Benedikt Weissbrich; Yvonne Süss-Fröhlich; Hermann J Girschick
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.